Diverging Trends in Registry-Coded No Primary-Site Surgery for Colon and Rectal Cancer: A SEER Study, 2000-2023
The American Surgeon™ · 02.11.2026
DOI: 10.1177/00031348261506127 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Surgeon™, online erschienen am 02.11.2026. Verfasst von Cigdem Benlice und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Istanbul Health and Technology University, Istanbul, Turkey. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Background
We evaluated temporal trends in registry-coded no primary-site surgery separately for colon and rectal adenocarcinoma using SEER data from 2000 through 2023.
Methods
Colon and rectal adenocarcinomas were identified. The endpoint was registry-coded no primary-site surgery, which cannot distinguish planned organ preservation, refusal, inoperability, or incomplete treatment capture. Site-specific trends were evaluated using linear and piecewise logistic models. Principal analyses, including post-2018 trends, were not stage-adjusted because AJCC stage in the extract covered only 2004-2015. Survival comparisons were descriptive.
Results
The cohort included 397 116 colon and 120 487 rectal cancers. Between 2000-2005 and 2018-2023, no primary-site surgery increased from 10.2% to 30.1% in rectal cancer and from 2.9% to 6.5% in colon cancer. Rectal cancer odds increased by 5.4% per year before 2018 and 17.5% per year after 2018. The colon trend was approximately linear, with a 4.2% annual increase in odds. A stage-adjusted analysis in the 2004-2015 stage I-III subset supported an earlier increase but could not evaluate the post-2018 acceleration.
Discussion
Registry-coded no primary-site surgery increased in both cancers, with a greater and accelerating rise in rectal cancer. These descriptive findings extend contemporary observations and support site-specific interpretation. The unadjusted post-2018 pattern cannot establish changes independent of stage or identify planned watch-and-wait, treatment refusal, or absence of cancer-directed therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, Istanbul Health and Technology University, Istanbul, Turkey.
- Department of General Surgery, Koç University Hospital, Istanbul, Turkey.
ORCID-Profile: Cigdem Benlice
Zitieren
APA
Benlice, C., & Yavuz, B. (2026). Diverging Trends in Registry-Coded No Primary-Site Surgery for Colon and Rectal Cancer: A SEER Study, 2000-2023. The American Surgeon™. https://doi.org/10.1177/00031348261506127
Vancouver
Benlice C, Yavuz B. Diverging Trends in Registry-Coded No Primary-Site Surgery for Colon and Rectal Cancer: A SEER Study, 2000-2023. The American Surgeon™. 2026. doi:10.1177/00031348261506127
BibTeX
@article{Benlice2026,
author = {Benlice, Cigdem and Yavuz, Burak},
title = {Diverging Trends in Registry-Coded No Primary-Site Surgery for Colon and Rectal Cancer: A SEER Study, 2000-2023},
journal = {The American Surgeon™},
year = {2026},
doi = {10.1177/00031348261506127}
}
EUVIMED